Today: 9 May 2026
Moon rush 2026: Blue Origin, Firefly, Intuitive Machines and Astrobotic line up lunar landings
6 January 2026
2 mins read

Moon rush 2026: Blue Origin, Firefly, Intuitive Machines and Astrobotic line up lunar landings

Seattle, Jan 6, 2026, 05:14 (PST)

  • Four private companies are targeting lunar landing attempts in 2026, led by Blue Origin, Firefly, Intuitive Machines and Astrobotic
  • NASA’s Artemis plans and China’s Chang’e-7 keep attention on the Moon’s south pole and harder-to-reach regions
  • NASA’s CLPS program remains a key customer as it buys commercial deliveries to the lunar surface

Private lunar landings are back on the calendar for 2026, with Blue Origin, Firefly Aerospace, Intuitive Machines and Astrobotic lining up robotic missions to the Moon. The run of attempts would add fresh pressure to prove that commercial lunar delivery can work more than once.

The push comes as NASA prepares Artemis II, a crewed flight around the Moon no earlier than February, and China aims a south-pole landing with Chang’e-7 in the second half of the year. The combined timetable is drawing renewed attention to the Moon as both a science target and a strategic proving ground.

Several of the missions connect to NASA’s Commercial Lunar Payload Services, or CLPS, a program that buys delivery services from U.S. companies for science instruments and technology demonstrations. NASA says CLPS contracts are structured for multiple task orders with a cumulative ceiling of $2.6 billion through 2028, and its public timeline lists Blue Origin’s Mark 1 mission as carrying the agency’s Stereo Cameras for Lunar Plume Surface Studies payload.

Blue Origin’s Blue Moon Mark 1 is designed as a single-launch cargo lander that can deliver up to three metric tons and test systems such as precision landing within about 100 meters of a target site, the company says. Blue Origin also describes the pathfinder flight as a step toward its uncrewed NASA Human Landing System work — NASA’s astronaut lunar-lander program.

Founder Jeff Bezos wrote on Instagram late last year that the MK1 flight vehicle “will land near Shackleton crater” and said, “We’ll soon be doing fully integrated checkout tests,” Primetimer reported. primetimer.com

Firefly’s Blue Ghost Mission 2 plans a far-side landing — terrain that has no direct line of sight to Earth and needs a relay for communications. The mission uses a two-spacecraft stack — Blue Ghost and Firefly’s Elytra Dark orbital vehicle — to deploy the European Space Agency’s Lunar Pathfinder satellite and support roughly 10 days of surface operations, Firefly said. The lander will power down before lunar night to avoid interfering with NASA’s LuSEE-Night radio telescope, which Firefly said could operate for up to two years.

Intuitive Machines is targeting a third landing attempt with its IM-3 mission, aiming for the Reiner Gamma region on the near side, Space.com reported. The company’s first two landers — Odysseus in February 2024 and Athena last year — ended up on their sides after touchdown, underscoring how thin the margin is in lunar landing design.

Astrobotic’s Griffin-1 is scheduled to launch no earlier than July 2026 on a SpaceX Falcon Heavy, Space.com said, after its first Peregrine lander failed to reach the Moon in 2024. Griffin-1 is now set to carry Astrolab’s 1,000-pound (450-kg) FLIP rover and Astrobotic’s smaller CubeRover; NASA’s VIPER rover has moved to a later mission, according to Space.com.

The new wave of missions also has a supply-chain angle far from Florida launchpads. Newstalk870, citing GeekWire, said an L3Harris Technologies team in Redmond, Washington, built thrusters for Artemis II’s Orion crew vehicle, while Blue Origin’s lunar lander work is based in Kent.

Stock Market Today

  • AbbVie Stock Evaluation: Undervalued After Recent Pullback or Overpriced?
    May 9, 2026, 10:02 AM EDT. AbbVie's shares fell 4.1% over the past week, trading near $202, yet posting strong returns of 12.8% over one year and nearly 110% over five years. Using a Discounted Cash Flow (DCF) model, Simply Wall St estimates AbbVie's intrinsic value at about $418.78 per share, implying the stock is undervalued by 51.6%. The DCF projects free cash flow growth from $18 billion to $34.3 billion by 2030. However, valuation scores are mixed, with 3 out of 6 points indicating some caution, reflecting investor reassessment amid shifts in healthcare and AI sector opportunities. AbbVie's peers have outperformed it recently, raising questions about its relative appeal. Investors should weigh these factors when considering an entry point for this large-cap pharmaceutical firm.

Latest article

Micron Stock Rally: AI Memory Shortage Sends Market Value Past $850 Billion

Micron Stock Rally: AI Memory Shortage Sends Market Value Past $850 Billion

9 May 2026
Micron Technology jumped over 15% Friday to $746.81, pushing its market value near $853 billion, as investors bet on soaring AI data center demand. The company reported fiscal Q2 revenue nearly tripled to $23.86 billion and net income of $13.79 billion. Micron forecast Q3 revenue of $33.5 billion and expects 2026 capital spending above $25 billion. Sandisk also rose more than 16% on similar demand.
Dow Jones today: Futures dip after record close as U.S. jobs report looms
Previous Story

Dow Jones today: Futures dip after record close as U.S. jobs report looms

Vistra stock jumps in premarket after $4.7 billion Cogentrix deal puts power demand in focus
Next Story

Vistra stock jumps in premarket after $4.7 billion Cogentrix deal puts power demand in focus

Go toTop